Inactive Instrument
Precision Therapeutics Inc Share Price Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 9.62Cr 8.57Cr 7.94Cr 7.18Cr 14Cr 907.87Cr 14Cr 95Cr 37Cr 477.21Cr 36Cr 35Cr 1.52TCr | P/E 2026 * |
-4.77x | P/E 2027 * | -75.5x |
|---|---|---|---|---|---|
| Enterprise Value | 9.62Cr 8.57Cr 7.94Cr 7.18Cr 14Cr 907.87Cr 14Cr 95Cr 37Cr 477.21Cr 36Cr 35Cr 1.52TCr | EV / Sales 2026 * |
1.59x | EV / Sales 2027 * | 0.22x |
| Free-Float |
93.93% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 9.62Cr | ||
| -0.21% | -6.36% | +49.00% | +74.13% | 6.63TCr | ||
| -0.22% | +10.10% | +12.77% | +87.32% | 5.29TCr | ||
| +0.82% | +9.46% | +7.75% | +73.53% | 5.48TCr | ||
| +3.28% | +5.58% | +26.51% | +50.58% | 4.41TCr | ||
| +0.51% | +9.95% | +22.40% | +129.04% | 4.37TCr | ||
| -1.15% | +0.39% | +263.21% | +958.46% | 4.21TCr | ||
| +0.10% | +9.96% | +17.15% | +59.33% | 3.4TCr | ||
| -1.30% | -3.61% | +37.37% | +7.16% | 2.62TCr | ||
| +0.69% | +6.07% | +31.89% | +26.94% | 2.34TCr | ||
| Average | -0.40% | +4.78% | +52.01% | +162.94% | 4.31TCr | |
| Weighted average by Cap. | +0.43% | +4.67% | +51.34% | +166.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.04Cr 5.38Cr 4.98Cr 4.51Cr 8.5Cr 569.97Cr 8.6Cr 60Cr 23Cr 299.6Cr 23Cr 22Cr 954.69Cr | 43Cr 38Cr 36Cr 32Cr 61Cr 4.07TCr 61Cr 426.63Cr 167.4Cr 2.14TCr 161.79Cr 158.43Cr 6.82TCr |
| Net income | -4.14Cr -3.69Cr -3.42Cr -3.09Cr -5.82Cr -390.68Cr -5.89Cr -41Cr -16Cr -205.35Cr -16Cr -15Cr -654.37Cr | -45L -40.1L -37.13L -33.6L -63.3L -42Cr -64.05L -4.45Cr -1.75Cr -22Cr -1.69Cr -1.65Cr -71Cr |
| Net Debt | - | - |
Employees
-
















